Zhilan Chai

1.3k total citations
16 papers, 1.1k citations indexed

About

Zhilan Chai is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Zhilan Chai has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Biomaterials and 5 papers in Biomedical Engineering. Recurrent topics in Zhilan Chai's work include Nanoparticle-Based Drug Delivery (11 papers), RNA Interference and Gene Delivery (8 papers) and Nanoplatforms for cancer theranostics (5 papers). Zhilan Chai is often cited by papers focused on Nanoparticle-Based Drug Delivery (11 papers), RNA Interference and Gene Delivery (8 papers) and Nanoplatforms for cancer theranostics (5 papers). Zhilan Chai collaborates with scholars based in China, South Korea and United States. Zhilan Chai's co-authors include Weiyue Lu, Changyou Zhan, Danni Ran, Linwei Lu, Xuefeng Hu, Cao Xie, Huitong Ruan, Kuan Jiang, Liangfang Zhang and Ronnie H. Fang and has published in prestigious journals such as ACS Nano, Advanced Functional Materials and ACS Applied Materials & Interfaces.

In The Last Decade

Zhilan Chai

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhilan Chai China	15	572	560	504	102	95	16	1.1k
Liangcen Chen China	9	569 1.0×	764 1.4×	454 0.9×	60 0.6×	71 0.7×	9	1.1k
Mengyin Jiang China	11	499 0.9×	563 1.0×	367 0.7×	53 0.5×	80 0.8×	11	1.0k
Huining He China	19	573 1.0×	530 0.9×	499 1.0×	112 1.1×	135 1.4×	44	1.3k
Kairong Shi China	20	825 1.4×	851 1.5×	657 1.3×	102 1.0×	111 1.2×	25	1.4k
Deyu Miao China	9	443 0.8×	481 0.9×	324 0.6×	50 0.5×	78 0.8×	15	895
Heng Mei China	14	360 0.6×	506 0.9×	557 1.1×	108 1.1×	111 1.2×	23	984
Tingting Lin China	12	467 0.8×	409 0.7×	373 0.7×	151 1.5×	104 1.1×	47	1.1k
Mingqing Yuan China	9	502 0.9×	554 1.0×	328 0.7×	46 0.5×	65 0.7×	10	827
Zimiao Luo China	16	467 0.8×	498 0.9×	730 1.4×	136 1.3×	167 1.8×	20	1.2k
Young-Eun Seo United States	12	357 0.6×	343 0.6×	252 0.5×	62 0.6×	63 0.7×	20	794

Countries citing papers authored by Zhilan Chai

Since Specialization

Citations

This map shows the geographic impact of Zhilan Chai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhilan Chai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhilan Chai more than expected).

Fields of papers citing papers by Zhilan Chai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhilan Chai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhilan Chai. The network helps show where Zhilan Chai may publish in the future.

Co-authorship network of co-authors of Zhilan Chai

This figure shows the co-authorship network connecting the top 25 collaborators of Zhilan Chai. A scholar is included among the top collaborators of Zhilan Chai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhilan Chai. Zhilan Chai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Ding, Yuan, Zhilan Chai, Jun Wang, et al.. (2024). All-stage targeted red blood cell membrane-coated docetaxel nanocrystals for glioma treatment. Journal of Controlled Release. 369. 325–334. 19 indexed citations

Li, Jinyang, Jiasheng Lu, Jianfen Zhou, et al.. (2020). A pentapeptide enabled AL3810 liposome-based glioma-targeted therapy with immune opsonic effect attenuated. Acta Pharmaceutica Sinica B. 11(1). 283–299. 10 indexed citations

Ran, Danni, Jianfen Zhou, Zhilan Chai, et al.. (2020). All-stage precisional glioma targeted therapy enabled by a well-designed D-peptide. Theranostics. 10(9). 4073–4087. 32 indexed citations

Li, Jinyang, Zhilan Chai, Jiasheng Lu, et al.. (2020). ɑvβ3-targeted liposomal drug delivery system with attenuated immunogenicity enabled by linear pentapeptide for glioma therapy. Journal of Controlled Release. 322. 542–554. 16 indexed citations

Guo, Haiyan, Ruifeng Wang, Dongli Wang, et al.. (2020). Deliver anti-PD-L1 into brain by p-hydroxybenzoic acid to enhance immunotherapeutic effect for glioblastoma. Journal of Controlled Release. 320. 63–72. 42 indexed citations

Lu, Linwei, Mingfei Zhang, Xiaoyi Wang, et al.. (2019). Baicalein enhances the antitumor efficacy of docetaxel on nonsmall cell lung cancer in a β‐catenin‐dependent manner. Phytotherapy Research. 34(1). 104–117. 16 indexed citations

Chai, Zhilan, Danni Ran, Linwei Lu, et al.. (2019). Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma. ACS Nano. 13(5). 5591–5601. 303 indexed citations

Chai, Zhilan, Linwei Lu, Huitong Ruan, et al.. (2019). Bortezomib Dendrimer Prodrug‐Based Nanoparticle System. Advanced Functional Materials. 29(14). 50 indexed citations

Ruan, Huitong, Zhilan Chai, Qing Shen, et al.. (2018). A novel peptide ligand RAP12 of LRP1 for glioma targeted drug delivery. Journal of Controlled Release. 279. 306–315. 67 indexed citations

10.

Zhang, Mingfei, Linwei Lu, Ying Man, et al.. (2018). Enhanced Glioblastoma Targeting Ability of Carfilzomib Enabled by a ^DA7R-Modified Lipid Nanodisk. Molecular Pharmaceutics. 15(6). 2437–2447. 26 indexed citations

11.

Man, Ying, Songli Wang, Mingfei Zhang, et al.. (2018). Myristic Acid-Modified ^DA7R Peptide for Whole-Process Glioma-Targeted Drug Delivery. ACS Applied Materials & Interfaces. 10(23). 19473–19482. 26 indexed citations

12.

Chai, Zhilan, Xuefeng Hu, Xiaoli Wei, et al.. (2017). A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery. Journal of Controlled Release. 264. 102–111. 215 indexed citations

13.

Chai, Zhilan, Xuefeng Hu, & Weiyue Lu. (2017). Cell membrane-coated nanoparticles for tumor-targeted drug delivery. Science China Materials. 60(6). 504–510. 39 indexed citations

14.

Guan, Juan, Zui Zhang, Xuefeng Hu, et al.. (2017). Cholera Toxin Subunit B Enabled Multifunctional Glioma‐Targeted Drug Delivery. Advanced Healthcare Materials. 6(23). 27 indexed citations

15.

Wei, Xiaoli, Jie Gao, Changyou Zhan, et al.. (2015). Liposome-based glioma targeted drug delivery enabled by stable peptide ligands. Journal of Controlled Release. 218. 13–21. 120 indexed citations

16.

Pang, Zhiqing, Peicheng Xu, Jingjing Zhao, et al.. (2014). Local delivery of minocycline-loaded PEG-PLA nanoparticles for the enhanced treatment of periodontitis in dogs. International Journal of Nanomedicine. 9. 3963–3963. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact